Suppr超能文献

COVID-19 感染者与未感染者接种疫苗前后甲状腺功能研究。

Study of thyroid function among COVID-19-affected and non-affected people during pre and post-vaccination.

机构信息

Bangladesh Reference Institute for Chemical Measurements (BRiCM), Dhaka, Bangladesh.

出版信息

BMC Endocr Disord. 2022 Dec 9;22(1):309. doi: 10.1186/s12902-022-01187-0.

Abstract

The novel coronavirus COVID-19 has caused a global pandemic with many long-ranging effects on the physiological balance of the human body. The impact of COVID-19 on the thyroid axis remains uncertain. Our aim was to assess the long-term consequences of COVID-19 infection and its vaccination with thyroid hormones. Thirty laboratory-confirmed COVID-19-positive patients with no vaccination record, thirty COVID-19-negative patients with vaccination records, and ten healthy subjects were retrospectively, and cross-sectionally enrolled in this study. An ELISA assay was performed to evaluate thyroid function tests, including the total triiodothyronine (TT3), total thyroxine (TT4), and thyroid stimulating hormone (TSH). We found decreased levels of TT3, average or low plasma T4 levels, and standard or slightly decreased TSH levels in unvaccinated COVID-19-positive patients than in the healthy group, while the vaccinated COVID-19-negative group had normal thyroid hormone levels compared to controls. The correlation between TT3 and TSH levels gradually shifted from no association to a negative pattern in the unvaccinated COVID-19-positive group. Again, a highly significant negative correlation between TSH and TT3 was observed on days above 150, although a slight fluctuation was noted on day 90. This pilot study from Bangladesh shows that abnormalities in thyroid function can be observed during COVID-19 infection and after vaccination, which gradually recovers over time.

摘要

新型冠状病毒 COVID-19 引发了全球大流行,对人体生理平衡产生了许多长期影响。COVID-19 对甲状腺轴的影响仍不确定。我们的目的是评估 COVID-19 感染及其接种甲状腺激素的长期后果。本研究回顾性和横断面纳入了 30 名实验室确诊的 COVID-19 阳性且无接种记录的患者、30 名 COVID-19 阴性且有接种记录的患者和 10 名健康对照者。采用 ELISA 法检测甲状腺功能试验,包括总三碘甲状腺原氨酸(TT3)、总甲状腺素(TT4)和促甲状腺激素(TSH)。我们发现,未接种 COVID-19 阳性患者的 TT3 水平降低,平均或低血浆 T4 水平,标准或稍低 TSH 水平,而接种 COVID-19 阴性组的甲状腺激素水平与对照组相比正常。未接种 COVID-19 阳性组 TT3 和 TSH 水平之间的相关性逐渐从无关联转变为负相关模式。此外,在第 150 天以上观察到 TSH 和 TT3 之间存在高度显著的负相关,尽管在第 90 天观察到略有波动。这项来自孟加拉国的初步研究表明,COVID-19 感染和接种后可观察到甲状腺功能异常,且随时间逐渐恢复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdf/9732974/24e7d529a1bf/12902_2022_1187_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验